June 6-10, 2020
London, UK
For more information please visit: https://www.eaaci.org/eaaci-congresses/eaaci-2020
Mast cell silencing: a novel therapeutic approach for urticarial and other mast cell-mediated diseases
Summary Chronic urticaria (CU) is a mast cell (MC)-dependent disease with limited therapeutic options. Current management strategies are directed at inhibiting IgE-mediated activation of MCs and
August 25, 2023
